Ildong Pharmaceutical signs ‘Fambir’ license agreement with Novartis

Published: 2018-01-29 12:40:14

Updated: 2018-01-29 12:40:14

Ildong Pharmaceutical(CEO Woong-Sup Yoon) announced on the 25^th that the company secured the Korean license of ‘Famvir(generic name: famciclovir),’ a Novartis’ viral herpes treatment, and has started to take marketing activities since this month.

Famvir is a prescription drug used to treat shingles and genital herpes infection and suppress recurrence of genital herpes infection. Particularly, ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.